Elopak ASA (ELO.XOSL) DCF Valuation
Every assumption below is yours to change. The defaults are derived from this company's own filing history, not from a house view.
Conservative
€12.01
65% overvaluedvs €34.45
Base
€26.04
24% overvaluedvs €34.45
Optimistic
€50.22
46% undervaluedvs €34.45
Where today's price sits
Today's price falls inside the modelled range.
Verdict
Today's price sits inside the range but 24% above the base case. Upside from here requires beating your own base assumptions.
Base free cash flow
€192M
Trailing twelve months
Historical FCF CAGR
+21.3%
Across 6 reported periods
Market implies
19.9%
Growth needed at 8% WACC
Terminal value share
69%
Of the base case valuation
Growth needed to justify today's price
At a 8.0% discount rate, today's price already assumes 19.9% annual free cash flow growth for ten years. Your base case assumes 20.0%, which is effectively the same bet.
Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.
Free cash flow history
The most recent period is the base every projection starts from. Compounded, that history is +21.3% a year.
Elopak ASA (ELO.XOSL) DCF: intrinsic value and margin of safety
Intrinsiqq's two-stage DCF values Elopak ASA (ELO.XOSL) at about €34.72 per share, or €26.04 with a 25% margin of safety. At €34.45 the stock looks around fair value. Every assumption is adjustable below; this is analysis, not investment advice.
Frequently asked
What is Elopak ASA's (ELO.XOSL) fair value?+
Intrinsiqq's two-stage discounted cash flow (DCF) model estimates an intrinsic value of about €34.72 per share for ELO.XOSL. It projects recent free cash flow forward at a growth rate that fades toward a long-run rate, then discounts those cash flows back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €26.04. The output moves with the growth and discount-rate inputs, so it is best read as a range, not a single number. You can change every assumption with the sliders on this tab.
Is Elopak ASA overvalued based on a DCF?+
At €34.45, ELO.XOSL trades around the base-case intrinsic value of about €34.72, a 0.8% discount to that estimate, so on this model it looks around fair value. A DCF is only one lens: a premium can be justified if the business grows faster or is higher quality than the base case assumes, which is exactly what the sliders let you test.
What growth is priced into Elopak ASA?+
The base case grows ELO.XOSL's free cash flow at about 20.0% a year before fading, against roughly 21.3% historical free-cash-flow growth. If the price implies growth well above what the company has actually delivered, the market is paying for optimism; if below, expectations are modest. Adjust the growth assumption on this tab to see what the current price is really betting on.
What is a good margin of safety for Elopak ASA?+
A margin of safety is the discount to intrinsic value you demand before buying, to protect against being wrong on the inputs. Intrinsiqq applies 25% by default, which turns ELO.XOSL's €34.72 intrinsic estimate into a €26.04 entry. Wider margins suit less predictable businesses; you can set your own on this tab. This is analysis from company filings, not investment advice.
Related stocks: Packaging & Containers
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.